Cited by 16Endometriosis Research and TreatmentReproductive System and PregnancyReproductive Biology and Fertility

Adjustment of progesterone administration after endometrial transcriptomic analysis does not improve reproductive outcomes in women with adenomyosis

Juárez-Barber, Elena, Cozzolino, Mauro, Corachán, Ana, Alecsandru, Diana, Pellicer, Nuria, Pellicer, Antonio, Ferrero, Hortensia·2023·Reproductive BioMedicine Online

Abstract

Research question Do patients with adenomyosis present a dysregulated endometrial receptivity that can be reversed with personalized embryo transfer (PET) by transcriptomic-based progesterone adjustment, improving IVF outcomes?Design A multicentre, retrospective, cohort study that transcriptomically analysed the endometrial receptivity of the endometrium in patients with adenomyosis (n = 81) and healthy women (n = 231). Subsequently, implantation, biochemical and clinical miscarriage, and live birth rates between adenomyosis patients with one previous implantation failure using donor oocytes who received (n = 59) or did not receive (n = 66) PET based on endometrial receptivity, were observed to evaluate if adjusted progesterone improves reproductive outcomes of adenomyosis patients.Results Patients with adenomyosis significantly presented an altered endometrial receptivity (non-receptive) compared with healthy patients (53.1% versus 37.2%, P = 0.0179), elevating the risk of adenomyosis patients having a non-receptive endometrium 42.59% higher (95% CI 41.50 to 44.45). No significant differences were found in implantation (62.7% versus 78.8%, P = 0.0514), biochemical (13.5% versus 3.9%, P = 0.1223) and clinical (10.8% versus 15.4%, P = 0.7543) miscarriage, or live birth rates (75.7% versus 80.8%, P = 0.6066), in patients with PET compared with those without PET.Conclusions Women with adenomyosis presented an altered expression of genes involved in decidualization, and a higher rate of non-receptive endometrial statuses than controls. Although progesterone is indispensable for implantation, adjusting progesterone before PET, using endometrial transcriptomic signatures, does not improve IVF outcomes in patients with adenomyosis. Other molecular mechanisms beyond progesterone regulation may be involved in implantation failure.

Integrity signals

Registry

Crossref · 10.1016/j.rbmo.2022.09.007

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Molecular mechanisms other than progesterone resistance may be involved in implantation failure.

    “Other molecular mechanisms beyond progesterone resistance may be involved in implantation failure (53).”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [53]

  • Women with adenomyosis have altered expression of genes involved in decidualization.

    “For example, Ju arez-Barber et al. (53) reported that women with adenomyosis have an altered expression of genes involved in decidualization.”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [53]

  • Adjusting progesterone doses before frozen embryo transfers did not improve ART outcome in patients with adenomyosis.

    “Their results indicate that adjusting progesterone doses before FETs did not improve the ART outcome in patients with adenomyosis.”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [53]

Cites

Flagged first, then by citations

2 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Juárez-Barber, E., Cozzolino, M., Corachán, A., Alecsandru, D., Pellicer, N., Pellicer, A., & Ferrero, H.
Affiliations
  • Universidad Rey Juan Carlos (ES)
  • Universitat de València (ES)
  • IVIRMA Global (ES)
  • Instituto de Investigación Sanitaria La Fe (ES)
Corresponding author
Cozzolino, Mauro
Venue
Reproductive BioMedicine Online
Publisher
Elsevier BV
Published
2023-01
Volume
46
Issue
1
Pages
99-106
ISSN
1472-6483 (ISSN-L)
OpenAlex
W4295941957
Cited by
16
References
52
Citations by year
2026: 5 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 1
FWCI
2.32
Type
journal article
Language
en
Open access
closed
Locations
  • Reproductive BioMedicine Online (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Generalitat Valenciana (APOSTD/2020/123)
  • Instituto de Salud Carlos III (FI19/00110, PI21/00184)
  • European Social Fund (CP20/00120)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
adenomyosis, endometrial receptivity, personalized embryo transfer, progesterone supplementation, IVF outcomes, implantation failure, decidualization, donor oocytes, live birth rate, miscarriage
MeSH terms
Abortion, Spontaneous, Endometrium, Female, Humans, Embryo Implantation, Pregnancy, Progesterone, Retrospective Studies, Cohort Studies, Transcriptome, Adenomyosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review